Abstract:Abstract Background Terpenoids are of high interest as chemical building blocks and pharmaceuticals. In microbes, terpenoids can be synthesized via the methylerythritol phosphate (MEP) or mevalonate (MVA) pathways. Although the MEP pathway has a higher theoretical yield, metabolic engineering has met with little success because the regulation of the pathway is poorly understood. Results We applied metabolic control analysis to the MEP pathway in Escherichia coli expressing a heterologous isoprene synthase gene ( isp S). The expression of isp S led to the accumulation of isopentenyl pyrophosphate (IPP)/dimethylallyl pyrophosphate (DMAPP) and severely impaired bacterial growth, but the coexpression of isp S and isopentenyl diphosphate isomerase ( idi ) restored normal growth and wild-type IPP/DMAPP levels. Targeted proteomics and metabolomics analysis provided a quantitative description of the pathway, which was perturbed by randomizing the ribosome binding site in the gene encoding 1-deoxyxylulose 5-phosphate synthase (Dxs). Dxs has a flux control coefficient of 0.35 (i.e., a 1% increase in Dxs activity resulted in a 0.35% increase in pathway flux) in the isoprene-producing strain and therefore exerted significant control over the flux though the MEP pathway. At higher dxs expression levels, the intracellular concentration of 2- C -methyl- d -erythritol-2,4-cyclopyrophosphate (MEcPP) increased substantially in contrast to the other MEP pathway intermediates, which were linearly dependent on the abundance of Dxs. This indicates that 4-hydroxy-3-methylbut-2-en-1-yl diphosphate synthase (IspG), which consumes MEcPP, became saturated and therefore limited the flux towards isoprene. The higher intracellular concentrations of MEcPP led to the efflux of this intermediate into the growth medium. Discussion These findings show the importance of Dxs, Idi and IspG and metabolite export for metabolic engineering of the MEP pathway and will facilitate further approaches for the microbial production of valuable isoprenoids.

Immunological Associations in Familial and Non-Familial Alzheimer Patients and Their Families

Engineering Microbes for Isoprene Production

Significantly Enhanced Production of Isoprene by Ordered Coexpression of Genes Dxs , Dxr , and Idi in Escherichia Coli

Combining Gal4p-mediated Expression Enhancement and Directed Evolution of Isoprene Synthase to Improve Isoprene Production in Saccharomyces Cerevisiae

A novel method for collecting and detecting amoxycillin in urine: a tool for testing antibiotic compliance in the community.

Enhanced Isoprene Production by Reconstruction of Metabolic Balance Between Strengthened Precursor Supply and Improved Isoprene Synthase in Saccharomyces Cerevisiae

Clean synthesis of isoprene with six E. coli engineering strains

Efforts Toward Industrial Biosynthesis of Isoprene

Engineering and manipulation of a mevalonate pathway in Escherichia coli for isoprene production

Dual regulation of cytoplasmic and mitochondrial acetyl-CoA utilization for improved isoprene production in Saccharomyces cerevisiae

The impairment of long-term memory formation by the phosphatase inhibitor okadaic acid

Quantitative insight into the metabolism of isoprene-producing Synechocystis sp. PCC 6803 using steady state 13C-MFA

Nursing at the crossroads.

Multi-modular engineering for renewable production of isoprene via mevalonate pathway in Escherichia coli

Analysis of Essential Isoprene Metabolic Pathway Proteins in Variovorax sp. Strain WS11

Enhanced isoprene biosynthesis in Saccharomyces cerevisiae by engineering of the native acetyl-CoA and mevalonic acid pathways with a push-pull-restrain strategy.

Isoprene Oxidation by the Gram-Negative Model bacterium Variovorax sp. WS11

Expanding the isoprenoid building block repertoire with an IPP methyltransferase from Streptomyces monomycini.

Combinatorial Pathway Optimization in Escherichia Coli by Directed Co‐evolution of Rate‐limiting Enzymes and Modular Pathway Engineering

Enhancing Bio-Isoprene Production in Escherichia Coli through a Combinatorial Optimization Approach

Investigation of the methylerythritol 4-phosphate pathway for microbial terpenoid production through metabolic control analysis